Australian billionaire brothers Jack and Sam Gance, alongside business partner Mario Verrochi, are reportedly in advanced talks to acquire the UK-based pharmacy and health retailer Boots. The potential deal, valued at approximately $10 billion, would mark one of the largest cross-border healthcare acquisitions in recent years. Sigma Healthcare, the company backed by the Gance brothers and Verrochi, is leading the negotiations, according to a Forbes report dated June 10, 2026.
Boots, a staple of the UK high street with over 2,200 stores, has been a target for consolidation as the retail pharmacy sector faces pressure from changing consumer habits and digital competition. A takeover by Sigma Healthcare could signal a strategic expansion beyond Australia, where the firm already operates a significant healthcare and pharmacy distribution network.
For content creators in the health, business, and retail niches, this development highlights growing interest in global pharmacy consolidation and the influence of private wealth in shaping industry landscapes. The transaction, if completed, would bring substantial operational and branding changes to a beloved UK institution, potentially impacting supplier relationships, store formats, and digital health services.
While neither Sigma Healthcare nor Boots has officially confirmed the talks, the reported valuation underscores the premium placed on established pharmacy chains with strong physical footprints and loyal customer bases. Observers note that any deal would likely face regulatory scrutiny in both the UK and Australia due to market concentration concerns.
The story underscores a broader trend where wealthy individuals and family-backed entities are pursuing transformative deals in essential services sectors. For creators tracking entrepreneurship, M&A activity, or healthcare innovation, this potential acquisition offers a case study in how legacy retail brands are being reimagined through transnational investment. Further details are expected as negotiations progress.